| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9098971 | Regional Anesthesia and Pain Medicine | 2005 | 5 Pages |
Abstract
Systemic administration of 2 mg/kg and 4 mg/kg of meloxicam at an early stage after nerve injury attenuated the development of tactile allodynia. These results suggest that COX-2 may be at least in part involved in the development of tactile allodynia in an L5 single spinal-nerve injury model.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Masahiro M.D., Masahiko M.D., Keiji M.D., Toshikatsu M.D., Ph.D., Hitoshi M.D.,